Skip to main content

Suicides by drug poisoning among the elderly in Sweden 1969–1996


Background: Previous studies have shown an association between the rates of suicide employing certain types of medications and the availability of those drugs. During recent years, prescription patterns of psychoactive drugs commonly used in suicides have undergone some major changes. This study examines whether altered prescription patterns are associated with changes in the rates of drug-related suicides in the elderly. Methods: An ecological study was performed, in which rates of suicide by drug poisoning were related to prescription sales of different psychotropic drugs, derived from the National Prescription Survey (1987–1996). Results: Benzodiazepines were the dominant drug type used by elderly persons who committed suicide by drug poisoning. Rates of suicide using benzodiazepines increased despite decreasing prescription sales. Decreasing tricyclic antidepressant sales and increasing SSRI (selective serotonin reuptake inhibitors) sales were paralleled by decreasing rates of suicides employing antidepressants. The fatality ratio (FR) decreased for the antidepressant group, increased for benzodiazepines and remained more or less unchanged for analgesics among the elderly during the study period. Conclusions: Rates of suicide using benzodiazepines increased in the elderly despite decreasing prescription sales. Benzodiazepines should be prescribed restrictively to this age group.

This is a preview of subscription content, access via your institution.

Author information

Authors and Affiliations


Additional information

Accepted: 29 July 1999

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Carlsten, A., Waern, M. & Allebeck, P. Suicides by drug poisoning among the elderly in Sweden 1969–1996. Soc Psychiatry Psychiatr Epidemiol 34, 609–614 (1999).

Download citation

  • Issue Date:

  • DOI:


  • Serotonin
  • Tricyclic
  • Reuptake Inhibitor
  • Serotonin Reuptake
  • Selective Serotonin Reuptake Inhibitor